FDA Inspection 1074982 — Emory University Hospital Midtown- Center for Transfusion & Cellular Therapies

Emory University Hospital Midtown- Center for Transfusion & Cellular Therapies — FEI 1071491

The FDA completed an inspection of Emory University Hospital Midtown- Center for Transfusion & Cellular Therapies on November 30, 2018 in Atlanta, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 30, 2018
Fiscal Year
2019
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Atlanta, GA (United States)